rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Eastman Chemical Company

EMN · NYSE

MaterialsChemicalsNot moving yet

EMN stood above a rising 150-day average in 19 of the last 52 weekly readings, and has been out of that trend for the last 7 weeks. It is 11.8% below that average now. Chemicals: 24% of its 85 stocks in an uptrend (−5 points in four weeks); Materials: 18% (−6 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 7
Industry in uptrend
24% -5 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$732K
Officials’ trades on record
12

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 19 of 52 weeks.

17 Apr – 16 Oct
18%38%59%Apr 26Jun 26Jul 26Sep 26Oct 26

Chemicals: A minority of its stocks are in an uptrend and the share has been slipping. Materials: Few of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$13.7M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

12 disclosed lines: House 11, Senate 0, executive 1; 9 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k15 Jun 2026filed 22 Aug 2026
Lisa C. McClain House: U.S. House ClerkMI09soldspouse$1k–$15k4 Aug 2025filed 12 Sep 2025
Lisa C. McClain House: U.S. House ClerkMI09boughtspouse$1k–$15k17 Jun 2025filed 13 Aug 2025
Robert P. Bresnahan, Jr. House: U.S. House ClerkPA08sold$1k–$15k15 May 2025filed 9 Jun 2025
Kathy E. Manning House: U.S. House ClerkNC06soldjoint$1k–$15k3 Aug 2022filed 14 Sep 2022
Kathy E. Manning House: U.S. House ClerkNC06boughtjoint$1k–$15k20 Jul 2022filed 10 Aug 2022
John H. Rutherford House: U.S. House ClerkFL04sold$1k–$15k16 Mar 2022filed 19 Apr 2022
Peter Meijer House: U.S. House ClerkMI03sold$1k–$15k16 Feb 2021filed 16 Mar 2021
Dean Phillips House: U.S. House ClerkMN03bought$1k–$15k2 Apr 2020filed 7 May 2020
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39sold$1k–$15k18 Mar 2020filed 16 Apr 2020
John H. Rutherford House: U.S. House ClerkFL04bought$1k–$15k28 Oct 2019filed 18 Dec 2019
Thomas MacArthur House: U.S. House ClerkNJ03sold$15k–$50k27 May 2015filed 7 Jun 2015

Insiders

Buy orders, 12 months0
Sale orders, 12 months2
Buyers · sellers0 · 1
WhoDidSharesTraded
Adrian James HoltSVP, Chf HR Ofcrsold3,283at $71.314 Aug 2026filed 6 Aug 2026
Adrian James HoltSVP, Chf HR Ofcrsold1,709at $77.055 May 2026filed 7 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

Everyone who traded it

Brett D. Begemann Company insiderDirector · last 7 Oct 20261 · 0
Damon J. Audia Company insiderDirector · last 7 Oct 20261 · 0
Donald W. Slager Company insiderDirector · last 7 Oct 20260 · 0
Eric L. Butler Company insiderDirector · last 7 Oct 20261 · 0
Humberto P. Alfonso Company insiderDirector · last 7 Oct 20260 · 0
James J. /ky Obrien Company insiderDirector · last 7 Oct 20261 · 0
Julie Fasone Holder Company insiderDirector · last 7 Oct 20261 · 0
Kim Ann Mink Company insiderDirector · last 7 Oct 20261 · 0
Linnie M. Haynesworth Company insiderDirector · last 7 Oct 20260 · 0
Renee J. Hornbaker Company insiderDirector · last 7 Oct 20260 · 5
Adrian James Holt Company insiderSVP, Chf HR Ofcr · last 4 Aug 20260 · 8
Donald J. Trump Executive branchWhite House Office · last 15 Jun 20261 · 0

Same industry

FF FutureFuelLeading+19%
IOSP InnospecLeading+15%
MEOH MethanexLeading+12%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202521.1%
Free cash flow marginFY 2025 · to 31 Dec 20254.8%
Cash conversionFY 2025 · to 31 Dec 2025205%
Debt to equityFY 2025 · to 31 Dec 20250.80×
Research spendFY 2025 · to 31 Dec 20252.9%
Revenue growthFY 2025 · to 31 Dec 2025-6.7%
Earnings per share growthFY 2025 · to 31 Dec 2025-46.5%
Dividend growthFY 2025 · to 31 Dec 20252.1%
Share count trendFY 2025 · to 31 Dec 20250.2%
Cash and equivalentsFY 2025 · to 31 Dec 2025$566.0M
Free cash flowFY 2025 · to 31 Dec 2025$424.0M

Analyst forecasts

No analyst forecasts yet.